| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.5 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |